January 22, 2021
Bulletin interne de l'Institut Pasteur
The first "Pasteur Medicine Quarter-Hour" session of 2021 was held on Monday January 18. This event, run by the Institut Pasteur Medical Department, explored the theme of COVID-19 vaccination. Guest speakers Odile Launay from Cochin Hospital and Daniel Floret from the Technical Committee on Vaccination were invited to speak about the vaccines in clinical development and to discuss the ethical and public health aspects of vaccine priorities and indications.
The presentations and subsequent discussions were an opportunity to address a wide range of questions surrounding the arrival of the COVID vaccines, including the following: What technologies are used in the vaccines that are arriving on the market? How were clinical trials carried out in record time? What stages took place before the vaccines were brought to market? How will they be rolled out across France? Who will be given priority? What questions remain unanswered about these vaccines? What clinical trials are currently being carried out in France? After these two presentations, Christiane Gerke will give an overview of the Institut Pasteur vaccines under development.
More than 280 of you followed the event in real time.
If you were unable to attend or if you want to watch the session again, the video is available here
Sign up to your Microsoft account with your login@pasteur.fr and then enter your Pasteur password.
Odile Launay is a professor of infectious diseases at Université de Paris, coordinating physician at the Cochin-Pasteur Clinical Investigation Center (CIC) and coordinator of the i-Reivac network (Innovative Clinical Research Network in Vaccinology) and the Covireivac platform, which coordinates COVID-19 vaccine clinical research in France.
Daniel Floret is a professor of pediatrics at Claude Bernard University Lyon 1 and deputy chair of the Technical Committee on Vaccination at the French National Health Authority (HAS), which draws up vaccine recommendations for France.